MedPath
NMPA Approval

Lenalidomide Capsules

国药准字HJ20210078

December 8, 2021

Drug Information

来那度胺胶囊

胶囊剂

25mg

化学药品

December 8, 2021

December 7, 2026

Company Information

Applicant Company

Formulation Unit-VII, Plot No.P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

Manufacturing Company

Formulation Unit-VII, Plot No.P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

来那度胺胶囊 - NMPA 批准文号 | MedPath